Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
January 01, 2025
Attending The 43rd Annual J. P. Morgan Healthcare Conference
Manoj Vyas (CEO – CBCC Global Research), Harakh Shah, PMP® (Head – Clinical Operations, USA), and Devang Pandya (AGM – Business Development) will be attending The 43rd Annual J. P. Morgan Healthcare Conference during 13 – 16 January 2025, at San Francisco, CA.
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
For more information on this conference, please visit: https://lnkd.in/eZBPTdbM
For business appointments please email us at: devang.pandya@cbcc.global
We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION
